New starting dose price
Mounjaro 2.5mg on Subscribe & Save is now £98.99 for new patients and £125.95 for returning patients.
Subscribe & Save prices for all other strengths stay the same.
Subscribe & Save prices (per pen)
| Strength | New patients | Returning patients |
|---|---|---|
| 2.5mg | £98.99 | £125.95 |
| 5mg | £149.99 | |
| 7.5mg | £177.99 | |
| 10mg | £197.99 | |
| 12.5mg | £211.99 | |
| 15mg | £228.99 | |
Your Subscribe & Save price is based on your prescribed strength. If your dose changes following your check-in and our prescriber's review, your subscription will continue at the price for your new strength, as shown above. We'll notify you of any price change before your next payment.
Your subscription renews every 28 days, not once per calendar month. You can cancel at any time. A £20 early exit fee applies if you cancel after an order has been dispatched but before your sixth order, in accordance with our subscription terms. After your sixth order, you can cancel without an exit fee.
One-time purchase prices
| Strength | Previous price | New price | You save |
|---|---|---|---|
| 2.5mg | £139.99 | £35.00 | |
| 5mg | £159.99 | £35.00 | |
| 7.5mg | £209.99 | £35.00 | |
| 10mg | £239.99 | £35.00 | |
| 12.5mg | £259.99 | £35.00 | |
| 15mg | £269.99 | £35.00 |
2-pen bundle prices
| Bundle | Bought separately | Bundle price | You save |
|---|---|---|---|
| 2.5mg + 5mg | £250.99 | £48.99 | |
| 5mg + 5mg | £289.99 | £29.99 | |
| 7.5mg + 7.5mg | £349.99 | £69.99 | |
| 7.5mg + 10mg | £369.99 | £79.99 | |
| 10mg + 10mg | £389.99 | £89.99 | |
| 10mg + 12.5mg | £399.99 | £99.99 | |
| 12.5mg + 12.5mg | £419.99 | £99.99 | |
| 12.5mg + 15mg | £434.99 | £94.99 | |
| 15mg + 15mg | £454.99 | £84.99 |
"Bought separately" is the one-time price of the same pens bought individually. All prescription treatments are subject to clinical assessment and approval.
What is Mounjaro (Tirzepatide) for Weight Loss?
Mounjaro® (tirzepatide) is a once-weekly injectable medication developed by Eli Lilly. Since November 2023, the MHRA (Medicines and Healthcare products Regulatory Agency) has authorised Mounjaro for use in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity, such as hypertension, dyslipidaemia, or obstructive sleep apnoea. Mounjaro represents a significant advancement in the medical treatment of obesity, offering a new therapeutic option for individuals struggling to achieve and maintain a healthier weight.
Benefits of Weight Loss
Losing weight offers numerous health benefits that can improve both your quality of life and long-term well-being. Achieving and maintaining a healthy weight helps reduce the risk of chronic conditions such as type 2 diabetes, heart disease, high blood pressure, and stroke. Weight loss can also improve joint health, reducing pain and stiffness associated with arthritis.
Additionally, weight loss can often lead to better sleep quality, increased energy levels, and enhanced mental health by lowering stress, anxiety, and reducing depression-like symptoms. For many, weight loss boosts confidence and supports a more active lifestyle, enabling greater participation in everyday activities and hobbies. Overall, effective weight management is a key step toward living a healthier, longer life.
How Mounjaro Works for Weight Loss
Mounjaro is a dual GIP and GLP-1 receptor agonist. It works by mimicking the actions of two key gut hormones:
- GIP (glucose-dependent insulinotropic polypeptide): Supports fat metabolism and insulin sensitivity.
- GLP-1 (glucagon-like peptide-1): Suppresses appetite, enhances satiety, and slows gastric emptying.
This dual hormone action helps reduce hunger, regulate calorie intake, and support sustained weight loss over time. Clinical trials have shown that tirzepatide can lead to substantial and clinically meaningful reductions in body weight, especially when combined with a reduced-calorie diet and increased physical activity.
Is Mounjaro Right for You?
Mounjaro is available by prescription and should be used under the guidance of a qualified healthcare professional. It is typically considered when lifestyle interventions alone are insufficient to achieve weight loss goals. Treatment is most effective when combined with long-term lifestyle changes, including dietary improvements and regular physical activity.
How is Mounjaro Taken?
Mounjaro (tirzepatide) is administered as a once-weekly subcutaneous injection, typically into the abdomen, thigh, or upper arm. The injection is delivered using a pre-filled multi-dose KwikPen containing 4 weekly doses, designed for easy at-home use. Patients can administer the injection themselves after receiving appropriate guidance from a healthcare provider. Mounjaro can be taken at any time of day, with or without food, and should be injected on the same day each week. This once-weekly injection makes Mounjaro a practical option for people managing busy schedules or those who are new to injectable weight loss treatments.
Dosage and Titration Schedule
Mounjaro is started at a low initial dose to help minimise side effects, particularly gastrointestinal symptoms such as nausea. The typical starting dose is 2.5 mg once weekly for four weeks. After this period, the dose is gradually increased in 2.5 mg increments every four weeks, based on individual response and tolerability. The maximum recommended dose for weight loss is 15 mg once weekly. This titration schedule allows the body to adjust to the medication while maximising both safety and effectiveness. Your healthcare provider will closely monitor your progress and adjust the dosage accordingly.
What Does the Research Say About Mounjaro?
Mounjaro has been extensively studied in both diabetes and weight loss populations. In the SURMOUNT clinical trials, tirzepatide demonstrated superior weight loss results compared to other medications, including GLP-1 receptor agonists like semaglutide (Wegovy). Participants without diabetes lost an average of 15% (5 mg) to 21% (15 mg) of their body weight over 72 weeks. These results have positioned Mounjaro as a leading treatment for obesity, now licensed in the UK for this indication. Ongoing research continues to evaluate its long-term safety, metabolic benefits, and potential role in preventing obesity-related conditions such as type 2 diabetes, heart disease, and sleep apnoea.
Mounjaro and Contraception
The effectiveness of birth control pills may be reduced when starting Mounjaro (tirzepatide) or after any increase in your dose. To ensure full contraceptive protection, it is essential to use an additional barrier method of contraception, such as condoms, or switch to a non-oral contraceptive method like an intrauterine device (coil) during this time. You should continue using these additional or alternative contraception methods for at least four weeks after starting Mounjaro, and for four weeks following any dose escalation. Always discuss your contraception options with your healthcare provider before beginning treatment with Mounjaro.
Mounjaro (Tirzepatide) and Pregnancy or Breastfeeding
Mounjaro must not be used or initiated during pregnancy, as its effects on an unborn baby are not known. Use effective contraception while you are using Mounjaro. If you are pregnant or suspect you might be pregnant, do not start or continue Mounjaro treatment, and consult your healthcare provider immediately to discuss safer alternatives. If you are planning a pregnancy, speak to us or your GP for advice before you start Mounjaro, or before you stop it if you are already using it. Similarly, Mounjaro should not be used while breastfeeding, as its effects on a nursing baby are unknown. If you are breastfeeding, talk to your healthcare provider before using Mounjaro to explore safer options for weight management.
How Are Wegovy and Mounjaro Different?
Mounjaro (tirzepatide) and Wegovy (semaglutide) are both injectable treatments used to support weight management, but they work in slightly different ways and may suit different patients. Wegovy is a GLP-1 receptor agonist, while Mounjaro targets both GLP-1 and GIP receptors, which may offer added benefits for some individuals. Both medications are taken once weekly and can be highly effective when combined with lifestyle changes. Choosing between them depends on factors such as treatment goals, side effect profile, availability, and individual response, which is why professional guidance is essential.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Generic Name | Tirzepatide | Semaglutide |
| Mechanism | Dual GLP-1 & GIP receptor agonist | GLP-1 receptor agonist |
| Weight Loss Efficacy | Mean weight loss over 72 weeks: 15% (5 mg), 19.5% (10 mg), 21% (15 mg); some variability | Mean weight loss at 2.4 mg: ~15%; some patients lost more than 15%. Mean weight loss at 7.2 mg: ~21% with around 1 in 3 patients losing 25% or more over 72 weeks with no early plateau |
| Cardiovascular Benefit | Outcome data in type 2 diabetes; not yet shown in obesity alone | Shown to reduce CV risk by ~20% |
| Dosing Frequency | Once weekly | Once weekly |
| Available Strengths | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg | 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg, 7.2 mg |
| Titration | Dose increased every 4 weeks | Dose increased every 4 weeks |
| Common Side Effects | Nausea, vomiting, diarrhoea, constipation, indigestion, headache | Nausea, vomiting, diarrhoea, constipation, indigestion, headache, dysaesthesia (reported with higher 7.2 mg dose) |
| Contraception | May reduce the effectiveness of the pill (see Mounjaro and Contraception above) | No effect on oral contraceptives |
| Availability / Supply | Widely available, no anticipated supply issues | Widely available, no anticipated supply issues |
Side Effects of Mounjaro
While Mounjaro (tirzepatide) is an effective treatment for weight management, it is important to be aware of potential side effects, both common and serious. Common side effects may include nausea, diarrhoea, decreased appetite, vomiting, constipation, indigestion, and stomach pain. These symptoms are typically mild to moderate in intensity and often improve over time. To minimise discomfort, healthcare professionals recommend gradual dose escalation, also known as titration, which allows the body to adjust to the medication in a stepwise manner.
Serious side effects: what to look out for and what to do
Although we don't expect most people to get these side effects, as they are less common, we still want you to know their signs and symptoms so you can get help promptly if ever needed.
1. Serious allergic reaction (anaphylaxis)
Signs and symptoms: swelling of the face, lips, tongue or throat, difficulty breathing or swallowing, wheezing, a severe rash or itching, feeling faint or dizzy, or a very fast heartbeat.
What to do: stop using Mounjaro and do not take another dose.
Where to get help: call 999 immediately.
2. Inflammation of the pancreas (pancreatitis)
Signs and symptoms: severe, persistent pain in the upper abdomen that may spread to your back, with or without nausea and vomiting.
What to do: stop using Mounjaro. If pancreatitis is confirmed, you must not restart it.
Where to get help: call 999 or go to A&E. Let us know once you have been seen.
3. Gallbladder problems
Signs and symptoms: pain in the upper right side of the abdomen, fever, yellowing of the skin or eyes (jaundice), or pale, clay-coloured stools.
What to do: do not take your next dose until you have been assessed.
Where to get help: contact your GP urgently or call NHS 111. If the pain is severe or you have yellowing of the skin or eyes, go to A&E. Let us know the outcome.
4. Dehydration
Signs and symptoms: ongoing vomiting or diarrhoea, feeling very thirsty, a dry mouth, passing little or dark urine, dizziness, or tiredness.
What to do: drink plenty of fluids, especially when you start treatment or increase your dose, and do not take your next dose until the symptoms have settled.
Where to get help: contact our clinical team or call NHS 111. If you cannot keep fluids down or are passing very little urine, see your GP the same day or go to A&E.
5. Severe or persistent stomach problems
Signs and symptoms: nausea, vomiting, stomach pain, diarrhoea or constipation that is severe or does not improve.
What to do: do not increase your dose, and keep drinking fluids.
Where to get help: contact our clinical team. We may need to lower your dose. If symptoms are severe, call NHS 111.
6. Low blood sugar (hypoglycaemia) (more likely if you take other diabetes medicines)
Signs and symptoms: shakiness, sweating, feeling hungry, dizziness, confusion, blurred vision, a fast heartbeat, or irritability.
What to do: eat or drink something sugary straight away, such as glucose tablets, a small glass of fruit juice or a non-diet fizzy drink, then have a snack once you feel better.
Where to get help: tell your GP or diabetes team, as your other diabetes medicines may need adjusting. Call 999 if someone becomes drowsy, cannot swallow or loses consciousness.
7. Changes in vision (mainly if you have diabetic eye disease)
Signs and symptoms: blurred or changing vision, new floaters, or dark patches.
What to do: keep your regular diabetic eye screening appointments.
Where to get help: tell your GP or optometrist promptly. For sudden loss of vision, go to A&E.
8. Changes in mood
Signs and symptoms: new or worsening low mood, anxiety, irritability, or loss of interest in things you usually enjoy.
What to do: do not ignore these changes, even if they seem mild.
Where to get help: contact our clinical team or your GP. If you have thoughts of harming yourself, call 999 or go to A&E. You can also call Samaritans free on 116 123, day or night.
9. Thyroid (precaution)
Signs and symptoms: a lump or swelling in the neck, hoarseness, difficulty swallowing, or shortness of breath.
What to do: tell your prescriber if you or a close family member have ever had medullary thyroid cancer (MTC) or MEN 2. Thyroid tumours were seen in animal studies, but it is not known whether this applies to humans.
Where to get help: if you notice any of these symptoms, contact your GP promptly and let us know.
10. Surgery or sedation
Why it matters: Mounjaro slows how quickly your stomach empties, which can increase the risk of food entering your lungs during a general anaesthetic or deep sedation.
What to do: tell every doctor, dentist or nurse treating you that you use Mounjaro before any planned procedure.
Where to get help: your surgical or anaesthetic team will advise whether to pause treatment beforehand.
Contact our clinical team: 0121 752 7584 or help@iqdoctor.co.uk. In an emergency, always call 999.
Mounjaro Patient Information Leaflet (PIL)
For more information on Mounjaro, please see the PIL, available via the link below:
Mounjaro Patient Information Leaflet
Patient Counselling
- Tirzepatide weight loss injections - such as Mounjaro - must be taken with a recommended healthy, balanced diet and a regular physical exercise routine.
- Watch our online video to learn proper weight loss injection techniques.
- Mounjaro (tirzepatide) should be injected on the same day each week, at any time of day, and can be injected before or after food.
- The dosage for this weight loss medication needs to be tapered up to avoid any gastrointestinal side effects. Start at 2.5 mg once weekly for 4 weeks, then increase in 2.5 mg steps at least every 4 weeks. Maintenance doses are 5 mg, 10 mg or 15 mg; maximum 15 mg once weekly.
- Inject into the front of the thigh, the back of the upper arm, or the abdomen at least 5 cm away from your belly button. Rotate injection sites each week.
- If a dose is missed, and it has been 4 days (96 hours) or less since your missed dose, take it as soon as you remember. If it has been more than 4 days, skip the missed dose and take your next dose on your usual day. Either way, then carry on with your normal once-weekly schedule.
- If you miss more than one dose in a row, do not restart at your usual dose without speaking to us first. Contact our clinical team, as you may need to restart at a lower dose to reduce the risk of side effects.
- You can change the day you take your weekly injection if you need to, as long as there are at least 3 days (72 hours) between two doses. Once you have chosen your new day, carry on injecting once a week on that day.
Special Warnings and Precautions for Use of Mounjaro
Serious side effects, contraception and surgery are covered in the sections above. Please also note the following.
History of pancreatitis or severe stomach conditions
Tell us during your consultation if you have ever had pancreatitis, or if you have a severe gastrointestinal condition such as gastroparesis, as tirzepatide has not been studied in people with severe gastrointestinal conditions and we may not be able to prescribe Mounjaro for you.
Patients with diabetes
Tirzepatide is not a substitute for insulin. Diabetic ketoacidosis has been reported in insulin-dependent patients whose insulin was stopped or reduced too quickly. We are unable to prescribe Mounjaro if you take insulin or a sulphonylurea (such as gliclazide), as these increase the risk of low blood sugar (hypoglycaemia). If your GP starts you on either while you are using Mounjaro, tell us straight away.
Diabetic retinopathy
Tirzepatide has not been studied in people with diabetic eye disease that needs active treatment, proliferative diabetic retinopathy or diabetic macular oedema. Rapid improvement in blood sugar control can temporarily worsen diabetic eye disease. If you have diabetic retinopathy, tell us during your consultation.
Interaction with other medicines
Tirzepatide slows stomach emptying and may affect how well other medicines taken by mouth are absorbed. This effect is greatest after your first dose and lessens over time. If you take a medicine that needs careful monitoring, such as warfarin or digoxin, tell us and your GP before starting, as you may need extra checks when you start treatment and after each dose increase.
Sodium
This medicine contains less than 1 mmol sodium (23 mg) per dose, i.e. it is essentially 'sodium-free'.
Order Journey — Step by Step
Note: We offer free delivery as part of the LillyDirect service. All deliveries are shipped using Royal Mail Tracked 24 or DPD next-day delivery. We endeavour to deliver all Mounjaro orders within 1–3 working days. This is counted from the time your prescription is approved by our prescriber, not from when you place your order. Saturday deliveries are dispatched on Friday using Royal Mail Tracked 24 for delivery on Saturday. All deliveries require a signature or PIN on delivery, so please make sure you are home to receive it.
Online Questionnaire
Complete our secure medical questionnaire so our prescribers can confirm treatment is safe and suitable for you.
Order & Payment
Place your order and pay — payment is held securely while the prescriber reviews your case.
If it's not suitable you will receive a full refund.Upload Images
Upload BMI images, a copy of your ID, and any additional evidence (if requested).
Check your spam/junk folder to avoid delays.Prescriber Review
A qualified clinician reviews your questionnaire and images. Respond promptly to any follow-up requests to avoid delays.
Approval & Dispatch
Orders approved before 12 midday are dispatched the same day for delivery within 1–3 working days. Orders approved after 12 midday are dispatched the next working day.
Our partners take every step to maintain cold chain conditions (2°C – 8°C) during storage and transport of your Mounjaro (tirzepatide) injection, as this provides a stable environment for the medicine.
- We recommend placing it in your refrigerator (2°C – 8°C) until you are ready to use it.
- Protect it from light by keeping it in its original carton.
- Do not freeze — if frozen, the pen should not be used.
If your pen arrives at room temperature (up to 30°C), you can still use it.
- Mounjaro (tirzepatide) injection can be kept at temperatures up to 30°C for a maximum of 30 days.
- Your 4 doses will take 21 days to complete based on a 7-day injection cycle, so there is ample time to complete your course.
- Store away from direct sunlight and heat.
- Always attach the pen cap before storage and never store with a needle attached.
Mounjaro Frequently asked questions
Everything you need to know about Mounjaro
Mounjaro is a prescription medicine for adults who want to lose weight and improve health problems linked to their weight. We may prescribe it for:
- Adults with obesity: a body mass index (BMI) of 30 or more
- Adults who are overweight: a BMI of 27 or more with at least one weight-related health condition, such as prediabetes or type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea, heart disease, polycystic ovary syndrome (PCOS) or osteoarthritis
Mounjaro works alongside a reduced-calorie diet and increased physical activity to help you lose weight and keep it off. A prescriber reviews every consultation before treatment is approved.
- Inject once a week, on the same day each week, into your tummy, thigh or upper arm
- You can inject at any time of day, with or without food
- Change the injection site each week
- Your dose starts low and increases gradually to reduce side effects
- Use it alongside a reduced-calorie diet and increased physical activity for the best results
Yes. We can continue your Mounjaro treatment if you send evidence that you've used it within the last 6 weeks. We won't start you on a higher dose than your last confirmed one. If it's been longer, or you've missed several doses, your prescriber may restart you on a lower dose, such as 5 mg or the 2.5 mg starting dose. Acceptable evidence is an invoice or dispensing label from your previous provider that clearly shows:
- Your full name
- The date it was dispensed
- The strength of your last Mounjaro order
Side effects such as nausea, diarrhoea and constipation are most common when you start or increase your dose, and they usually ease over time. To help:
- Increase your dose gradually: only step up when your prescriber agrees. Staying on a dose for longer is fine if you're still losing weight.
- Eat smaller meals: stop when you feel full, and go easy on fatty, fried or very sugary food.
- Drink plenty of fluids: this helps prevent dehydration, especially if you have vomiting or diarrhoea.
- Talk to us: our clinicians can suggest ways to manage side effects and adjust your plan if needed.
Losing weight with Mounjaro isn't just about appearance. Clinical trials have shown improvements in:
- Blood pressure
- Cholesterol and blood sugar levels
- Mobility and physical function
- Quality of life
Even a 5–10% weight loss can lower the risk of type 2 diabetes, heart disease and some cancers.
After you order Wegovy, your clinician will email you asking for:
- BMI photos
- Proof of your previous treatment, such as a dispensing label or invoice dated within the last 6 weeks
If your current BMI is under 25, you may also need evidence of your starting weight, such as a letter from your previous healthcare provider. This helps your clinician choose the right dose and plan a safe switch.
Yes, if you take the contraceptive pill. Mounjaro may make oral contraceptives less effective, especially when you start treatment or increase your dose. Switch to a non-oral method (such as a coil, implant or injection), or use a barrier method such as condoms as well as your pill:
- for 4 weeks after starting Mounjaro
- for 4 weeks after each dose increase
Mounjaro must not be used during pregnancy or breastfeeding. If you're planning a pregnancy, speak to us first: you'll need to stop Mounjaro at least 1 month before trying to conceive. If you become pregnant while taking it, stop and contact us straight away.
Possibly. Interim guidance from the British Menopause Society (BMS) covers women taking HRT alongside weight-loss injections such as Mounjaro. These medicines slow digestion, which may reduce how well tablets are absorbed.
- Oestrogen: your GP or menopause specialist may suggest switching from tablets to a patch, gel or spray, which is absorbed through the skin.
- Progesterone: if you take oral progesterone (such as Utrogestan), your GP may recommend doubling the dose for 4 weeks after you start Mounjaro and for 4 weeks after each dose increase, to keep protecting the womb lining. Alternatively, they may suggest a Mirena coil, which releases progestogen directly into the womb.
Important: never change your HRT dose yourself. Always speak to your GP or menopause specialist first.
Mounjaro Subscribe & Save: your questions answered
Lower prices, one pen at a time, and a prescriber checking in with you every month.
Subscribe & Save at a glance
- Pay less for every pen. Subscribe & Save prices are lower than our one-off prices at every strength.
- No need to reorder. We remind you when your check-in opens, and your next pen follows automatically.
- Spread the cost. You pay for one pen at a time, every 28 days, with no large upfront payment.
- Stay in control. Choose your preferred doses for your next two pens at each check-in.
- Free delivery on every order.
- Our lowest price, with a 6-month commitment. After 6 months, you can cancel any time at no cost.
Here's what you pay per pen with Subscribe & Save compared with a one-off order:
| Strength | One-off price | Subscribe & Save | You save per pen |
|---|---|---|---|
| 2.5mg | £139.99 | £98.99 | £41.00 |
| 5mg | £159.99 | £149.99 | £10.00 |
| 7.5mg | £209.99 | £177.99 | £32.00 |
| 10mg | £239.99 | £197.99 | £42.00 |
| 12.5mg | £259.99 | £211.99 | £48.00 |
| 15mg | £269.99 | £228.99 | £41.00 |
Over a year (13 pens), that's a saving of up to £624. You can see the current price for each strength using the toggle at the top of this page.
How it works
- Choose Subscribe & Save at the top of this page and select your strength.
- Complete your online consultation and upload any photos or evidence we ask for.
- One of our UK prescribers reviews your answers.
- Once approved, your first pen is dispatched with free delivery.
Each cycle is 28 days, counted from your previous order:
| When | What happens |
|---|---|
| Day 14 | Your check-in opens and we email you a link to your patient dashboard. |
| Day 14 to day 24 | You complete your check-in. We'll send you a reminder if you haven't done it yet. |
| By day 26 | Your prescriber reviews your check-in and approves your next pen. |
| Day 28 | Your card is charged and your pen is dispatched. |
Complete your check-in correctly by day 24 and you'll always get the Subscribe & Save price.
Yes. At each check-in, you choose your preferred doses for your next two pens. Your prescriber reviews your answers, takes your preferences into account and confirms the right dose for you. If they recommend staying where you are, they'll explain why.
Your choices also cover you if you ever miss a check-in.
Payments
Checking in is quick and simple, and we'll remind you along the way. We email you when your check-in opens on day 14, and send you reminders before day 24.
If you do miss one, you're covered. Your last check-in already set your preferred dose for your next pen, so we'll send it as normal at the Subscribe & Save price.
Your first check-in is the exception. As there are no earlier preferences to use, we can't send your next pen until you've completed it.
If you miss two check-ins in a row, we'll need you to check in before we can send your next pen.
Checking in by day 24 is part of the terms for the Subscribe & Save pricing. If you check in late and there are no preferences from your last check-in to cover you, we'll send your pen once you've checked in, charged at the one-off price.
Your next pen goes back to the Subscribe & Save price as long as you check in on time.
Flexibility
Yes. Just raise a support ticket from your patient dashboard, call us on 0121 752 7584, or email help@iqdoctor.co.uk.
After your 6-month minimum term, cancelling your subscription is free.
Please note that once a pen has been dispatched, it can't be returned or refunded.
Yes, although Subscribe & Save gives you our most affordable price, with a simple, hassle-free way to get your pen every month.
If you'd rather not have a subscription, our two-pen bundles still offer big savings, and one-off orders are available too. Choose your option using the toggle at the top of this page.
Care and support
*A £20 exit fee applies if you cancel within your first 6 months.
Our Clinical Authors
This page has been written by a registered UK pharmacist and reviewed by our clinical team to ensure it is accurate, clear and reflects current clinical guidance.
Last medically reviewed: 02 November 2026
Last updated: 02 November 2026
We’re making ongoing care more affordable.
We’ve recently reviewed our pricing as part of our commitment to providing accessible, transparent healthcare.
You can view the latest pricing information and available care options as you explore our service.
All prescription treatments are subject to clinical assessment and approval.